Risedronate Sodium

3 Drugs classified under this active ingredient

Biphosphonate. Risedronate Sodium 150 mg.
TABS.:1. 1 tab. once a month. should be admin. with full glass of tap water, first thing upon rising in the morn., and at least 30 min. before breakfast, before drink. anything (except for tap water) or before taking any med. The pt. shouldn’t lie down for 30 min. after taking the med.
Prevention of osteoporosis in postmenopausal women.
C/I: Hypersens. Preg., lact. Pts. with dysphag. Pts. who are unable to remain in an upright posit. (sitting or standing) for 30 min. after admin. of the drug. Pts. with hypocalcem. that has not yet been stabiliz.
Severe renal impair. (CrCl below 30 ml/min.). Pts. with galactosemia, glucose and galactose absorpt. problems or lactase deficits.

Bisphosphonate. Risedronate Sodium 35 mg.
TABS: 4. 1 tab wkly. to be
swallowed whole and not sucked or
chewed in an upright position with
glass of plain water, at least 30 mins.
bef. first food, other medicine or drink
(except water) of the day. Pts should
not lie down for 30 mins aft. taking
tab.
Tmt. postmenopaus. osteoporos:,
established postmenopaus.
osteopor,
prevent. osteopor. in postmenopaus.
women with incr. risk of osteopor. Tmt.
osteopor. in men, at high risk of
fracture.
C/I: Known hypersens., hypocalcem.,
pregn. lact., severe ren. impair.

Bisphosphonate. Risedronate Sodium 150 mg.
Tab. X1
Orally once a month. to be taken
on the same date each month.
Absorption is affected by food and polyvalent cations.
To ensure adequate absorption pts. should take this drug
at least 30 minutes before the first food with tap water and stand or sit upright for at least 30 minutes. See lit.
Treatment of postmenopausal osteoporosis. Prevention of postmenopausal osteoporosis.
C/I:  Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia /Inability to stand or sit upright for at least 30 minutes
Hypocalcemia / Hypersensitivity